Who owns Dare Bioscience?
- CUSIP Number: 23666p101
Tip: Access positions for across all investors
Analyze quarterly positions in Dare Bioscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Dare Bioscience stock
Who bought or sold Dare Bioscience this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 3.4M | $1.1M | -3% | Jun 2024 |
|
State Street Corporation | 282k | $95k | 14% | Jun 2024 |
|
BlackRock | 204k | $68k | -49% | Jun 2024 |
|
Two Sigma Securities | 103k | $35k | 209% | Jun 2024 |
|
Wealth Enhancement Advisory Services | 31k | $10k | 0% | Jun 2024 |
|
Tower Research Capital | 15k | $5.1k | -25% | Jun 2024 |
|
Who sold out of Dare Bioscience?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Geode Capital Management | Jun 2024 | 1.0M | $371k |
AMH Equity | Jun 2024 | 924k | $310k |
Renaissance Technologies | Jun 2024 | 779k | $262k |
Northern Trust | Mar 2024 | 183k | $90k |
Commonwealth Equity Services | Jun 2024 | 46k | $15k |
Susquehanna International | Jun 2024 | 35k | $12k |
Charles Schwab Investment Management | Jun 2024 | 31k | $10k |
Bank of New York Mellon | Jun 2024 | 26k | $8.7k |
Raymond James Financial Services Advisors | Jun 2024 | 20k | $6.7k |
Advisor Group Holdings | Mar 2024 | 20k | $9.8k |